|
MechanismIGF-1R antagonists |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Curative Health Services, Inc.
0 Patents (Medical) associated with Curative Health Services, Inc.
Review
Author: Schutzius, P
100 Deals associated with Curative Health Services, Inc.
100 Translational Medicine associated with Curative Health Services, Inc.